Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predicting the course of Covid-19 and other epidemic and endemic disease

Ana Cascon, William F. Shadwick
doi: https://doi.org/10.1101/2021.12.26.21268419
Ana Cascon
Omega Analysis Research, 40 Bowling Green Lane, London EC1R 0NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Cascon{at}OmegaAnalysis.com
William F. Shadwick
Omega Analysis Research, 40 Bowling Green Lane, London EC1R 0NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The Gompertz Function is an accurate model for epidemics from Cholera in 1853 to Spanish Flu in 1918 and Ebola in 2014. It also describes the acute phase of annual outbreaks of endemic influenza and in all of these instances it has significant predictive power.

For Covid-19, we show that the Gompertz Function provides accurate forecasts not just for cases and deaths but, independently, for hospitalisations, intensive care admissions and other medical requirements. In particular Gompertz Function projections of healthcare requirements have been reliable enough to allow planning for: hospital admissions,intensive care admissions,ventilator usage, peak loads and duration.

Analysis of data from the ‘Spanish Flu’ pandemic and the endemic influenza cycle reveals alternating periods of Gompertz Function growth and linear growth in cumulative cases or deaths. Linear growth means the Reproduction Number is equal to 1 which in turn indicates endemicity.

The same pattern has been observed with Covid-19. All the initial outbreaks ended in linear growth. Each new outbreak has been preceded by a period of linear growth and has ended with a transition from Gompertz Function growth to linear growth. This suggests that each of these outbreak cycles ended with a transition to endemicity for the current dominant strain and that the normal seasonal respiratory virus periods will continue to see new outbreaks. It remains to be seen if widespread vaccination will disrupt this cyclicality.

Because both Gompertz Function Growth and linear growth are accurately predictable, the forecasting problem is reduced to identifying the transition between these modes and to improving the performance in the early Gompertz Function growth phase where its predictive power is lowest.

The dynamics of the Gompertz Function are determined by the Gumbel probability distribution. This is an exceptional distribution with respect to the geometry determined by the affine group on the line which is the key to the role of the Gumbel distribution as an Extreme Value Theory attractor. We show that this, together with the empirically observed asymmetry in epidemic data, makes the Gompertz Function growth essentially inevitable in epidemic models which agree with observations.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Covid-19 data presented in our analysis were taken from: Sweden: https://www.socialstyrelsen.se London: https://coronavirus.data.gov.uk Isle de France: https://www.data.gouv.fr Ontario: https://covid-19.ontario.ca Portugal: https://github.com/dssg-pt/covid19pt-data Amazonas and Rio de Janeiro: https://datasus.saude.gov.br/

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Shadwick{at}OmegaAnalysis.com

  • ↵* We are grateful to IMPA, Brazil for hospitality while this work was carried out.

Data Availability

The Covid-19 data presented in our analysis were taken from: Sweden: https://www.socialstyrelsen.se London: https://coronavirus.data.gov.uk Isle de France: https://www.data.gouv.fr Ontario: https://covid-19.ontario.ca Portugal: https://github.com/dssg-pt/covid19pt-data Amazonas and Rio de Janeiro: https://datasus.saude.gov.br/

https://www.socialstyrelsen.se

https://coronavirus.data.gov.uk

https://www.data.gouv.fr

https://covid-19.ontario.ca

https://github.com/dssg-pt/covid19pt-data

https://datasus.saude.gov.br/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 29, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predicting the course of Covid-19 and other epidemic and endemic disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predicting the course of Covid-19 and other epidemic and endemic disease
Ana Cascon, William F. Shadwick
medRxiv 2021.12.26.21268419; doi: https://doi.org/10.1101/2021.12.26.21268419
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Predicting the course of Covid-19 and other epidemic and endemic disease
Ana Cascon, William F. Shadwick
medRxiv 2021.12.26.21268419; doi: https://doi.org/10.1101/2021.12.26.21268419

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)